ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients

Teilah Kathryn Huth(Griffith University), Sonya Marshall‐Gradisnik(Griffith University)

Journal of Translational Medicine

April 21, 2016

10.1186/s12967-016-0859-z

Cited by 47

Related Papers

A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques

|PLoS ONE|2020|65